EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Editorial

One-week triple her therapies for Helicobacter pylori eradication

Ahmet AYDIN ¹ , Galip ERSÖZ ² , Müge TUNÇYÜREK ³ , Hanefi ÇAVUŞOĞLU ⁴

Author Affiliation(s)

1.

İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Çocuk Sağlığı ve Hastalıkları anabilim Dalı, İstanbul

2.

Ege Üniversitesi Tıp Fakültesi Gastroenteroloji ve Mikrobiyoloji Anabilim Dalları, İzmir

3.

Department of Gastroenenterology and Pathology İstanbul

4.

Ege Üniversitesi Tıp Fakültesi, Namık Kemal Menteş Gastroenteroloji Kliniği, İzmir

Turk J Gastroenterol 1998; 9: 40-45

Keywords : helicobacter pylori treatment, omeprazole, amoxicilin, clarithromycin, metronidazole.

Read: 1568 Downloads: 1372 Published: 25 July 2019

Volume 9, Issue 1, March 1998

Previous Article

Files